Analytica Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.00
Dividend & YieldN/A$ (N/A)
Beta 0.73
Market capitalization 4.61M
Operating cash flow -2.42M
ESG Scores unknown

Company description

Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -57.21k 95.76k -2.74k -95.84k
Total Cashflows From Investing Activities -48.47k -52.27k -84.63k -78.51k
Net Borrowings 75k 75k 75k -75.15k
Total Cash From Financing Activities 3.76M 861.13k 69.69k 3.44M
Change To Operating Activities 60.13k 15.73k -40.42k 37.07k
Issuance Of Stock 3.94M 913k 3.83M 3.83M
Net Income -2.16M -2.05M -1.62M -1.51M
Change In Cash 1.63M -1.07M -1.7M 1.82M
Effect Of Exchange Rate
Total Cash From Operating Activities -2.08M -1.88M -1.69M -1.54M
Depreciation 12.57k 10.85k 8.63k 9.2k
Change To Account Receivables 5.6k -1.95k 1.22k 1.39k
Other Cashflows From Financing Activities -182.18k -51.87k -5.32k -313.66k
Change To Netincome 5.47k 32.84k -41.21k 83.94k
Capital Expenditures -4.17k -4.48k -4.48k -4.48k

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development
Income Before Tax -2.16M -2.05M -1.62M -1.51M
Net Income -2.16M -2.05M -1.62M -1.51M
Selling General Administrative 1.28M 1.11M 935.03k 1.03M
Gross Profit -847.56k -895.25k -710.32k -316.68k
Ebit -2.18M -2.03M -1.6M -1.45M
Operating Income -2.18M -2.03M -1.6M -1.45M
Interest Expense -277 -2.78k -227 -58.5k
Income Tax Expense
Total Revenue 998.19k 811.28k 805.9k 801.43k
Cost Of Revenue 1.85M 1.71M 1.52M 1.12M
Total Other Income ExpenseNet 24.79k -24.84k -15.18k -61.19k
Net Income From Continuing Ops -2.16M -2.05M -1.62M -1.51M
Net Income Applicable To Common Shares -2.16M -2.05M -1.62M -1.51M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 455.11k 571.49k 673.9k 516.77k
Total Stockholder Equity 2.85M 1.67M -6.24k 2.09M
Other Current Liabilities 51.65k 40.7k 119.67k 41.73k
Total Assets 3.3M 2.24M 667.65k 2.61M
Common Stock 103.01M 103.87M 103.87M 107.38M
Other Current Assets 4.77k 33.87k 8.67k
Retained Earnings -101.56M -103.13M -104.73M -106.19M
Treasury Stock 1.4M 927.49k 852.19k 900.07k
Cash 2.84M 1.77M 66.22k 1.89M
Total Current Liabilities 420.08k 562.1k 664.34k 505.53k
Other Stockholder Equity 1.4M 927.49k 852.19k 900.07k
Property, Plant, and Equipment 19.17k 12.26k 7.56k 8.69k
Total Current Assets 3.06M 1.98M 336.15k 2.2M
Net Tangible Assets 2.66M 1.43M -322.16k 1.71M
Net Receivables 19.59k 21.54k 20.32k 18.93k
Accounts Payable 142.43k 248.04k 166.62k 149.71k


Insider Transactions

Here are the insider transactions of stock shares related to Analytica Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Monsour (Michael Phillip)D2021-12-22Chairman of the Board3.27M
Mangelsdorf (Ross James)D2021-06-18Director (Non-Executive)1.11M
Monsour (Michael Phillip)D2021-06-18Chairman of the Board214.29M
Mangelsdorf (Ross James)D2019-06-07Director (Non-Executive)16.53M
Monsour (Michael Phillip)D2019-06-07Chairman of the Board103.3M
Daly (Geoff)D2018-06-30Chief Executive Officer1.2M
Mangelsdorf (Ross James)D2018-06-13Director (Non-Executive)8.63M
Mangelsdorf (Ross James)Exercise at price 0.00 per share.D2018-06-13Director (Non-Executive)2.7M
Monsour (Michael Phillip)D2018-06-13Chairman of the Board70.56M
Mangelsdorf (Ross James)Exercise at price 0.08 per share.D2018-02-07Director (Non-Executive)11.26M
Monsour (Michael Phillip)Exercise at price 0.00 per share.D2018-02-07Chairman of the Board70.56M
Stubbings (Carl Stephen)D2017-11-30Former3.09M
Corr (Peter B)Acquisition at price 0.01 per share.D2017-10-19Director (Non-Executive)40.09M
Mangelsdorf (Ross James)Acquisition at price 0.01 per share.D2017-10-19Director (Non-Executive)11.32M
Monsour (Michael Phillip)Acquisition at price 0.00 per share.D2017-10-19Chairman of the Board70.56M
Stubbings (Carl Stephen)Acquisition at price 0.00 per share.D2017-10-19Director (Non-Executive)343.29k
Mangelsdorf (Ross James)Other at price 0.00 per share.D2017-04-24Director (Non-Executive)10.17M
Monsour (Michael Phillip)D2017-04-24Chairman of the Board64.92M
Monsour (Michael Phillip)Other at price 0.00 per share.D2016-04-26Chairman of the Board333.33M
Monsour (Michael Phillip)D2016-04-26Chairman of the Board2.04M
Mangelsdorf (Ross James)Other at price 0.00 per share.D2016-04-20Director (Non-Executive)19.41M
Mangelsdorf (Ross James)Other at price 0.01 per share.D2015-08-11Director (Non-Executive)7.84M
Monsour (Michael Phillip)Other at price 0.01 per share.D2015-08-11Chairman of the Board50.02M
Stubbings (Carl Stephen)Other at price 0.01 per share.D2015-08-11Director (Non-Executive)915.44k
Monsour (Michael Phillip)Purchase at price 0.02 per share.D2014-12-18Chairman of the Board282k
Monsour (Michael Phillip)Purchase at price 0.02 per share.D2014-12-16Chairman of the Board65k
Mangelsdorf (Ross James)Other at price 0.03 per share.D2014-11-05Director (Non-Executive)1.85M
Monsour (Michael Phillip)Acquisition at price 0.03 per share.D2014-11-05Chairman of the Board13.35M
Stubbings (Carl Stephen)Other at price 0.03 per share.D2014-11-05Director (Non-Executive)203.43k
Monsour (Michael Phillip)Other at price 0.03 per share.D2014-09-08Chairman of the Board15.5M
Mangelsdorf (Ross James)Other at price 0.02 per share.D2014-05-22Director (Non-Executive)1.21M
Monsour (Michael Phillip)D2014-05-22Chairman of the Board15.06M
Monsour (Michael Phillip)Purchase at price 0.03 per share.D2014-03-31Chairman of the Board50k
Monsour (Michael Phillip)Purchase at price 0.02 per share.D2014-03-27Chairman of the Board50k
Mangelsdorf (Ross James)Purchase at price 0.02 per share.D2014-03-11Director (Non-Executive)450k
Monsour (Michael Phillip)Purchase at price 0.02 per share.D2014-03-11Chairman of the Board821k
Brooks (Warren Stephen)Other at price 0.02 per share.I2013-11-11Director (Non-Executive)882.35k
Mangelsdorf (Ross James)D2013-11-11Director (Non-Executive)4.71M
Mangelsdorf (Ross James)D2013-11-11Director (Non-Executive)2.39M
Monsour (Michael Phillip)D2013-11-11Chairman of the Board22.37M
Brooks (Warren Stephen)Other at price 0.02 per share.I2013-06-27Director (Non-Executive)4.25M
Mangelsdorf (Ross James)Purchase at price 0.02 per share.D2013-06-27Director (Non-Executive)1.75M
Brooks (Warren Stephen)Other at price 0.02 per share.I2012-12-15Director (Non-Executive)3M
Monsour (Michael Phillip)Other at price 0.02 per share.D2012-12-15Chairman of the Board3M
Brooks (Warren Stephen)Sale at price 0.02 per share.I2012-09-05Director (Non-Executive)1.5M
Monsour (Michael Phillip)Other at price 0.02 per share.D2012-09-05Chairman of the Board1.5M
Brooks (Warren Stephen)Acquisition at price 0.02 per share.I2012-03-09Director (Non-Executive)9.58M
Mangelsdorf (Ross James)D2012-03-09Director (Non-Executive)7.18M
Monsour (Michael Phillip)Acquisition at price 0.02 per share.D2012-03-09Chairman of the Board23.94M
Brooks (Warren Stephen)Acquisition at price 0.02 per share.I2011-12-16Director (Non-Executive)7.41M
Mangelsdorf (Ross James)D2011-12-16Director (Non-Executive)1.8M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Analytica Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Analytica Limited

Here is the result of two systematic investment strategies applied to Analytica Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Analytica Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Analytica Limited:

Analytica Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -21.83% on the backtest period.

Performance at glance

Performance

-21.83 %

Latent gain

-545.84 $

Invested capital

2500.01 $

Annualized return

-5.27 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Analytica Limited

This is the result of two momentum investment strategies applied to Analytica Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Analytica Limited

The following chart shows all the entries opened by the momentum investment system on Analytica Limited:

Analytica Limited momentum entries
  • The first momentum investment strategy would give -6.39% of return on Analytica Limited. That represents -575.0$ of latent gain with 9000.0$ of employed capital.
  • The second momentum investment strategy would give -3.75% of return on Analytica Limited. That represents -262.5$ of latent gain with 7000.0$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-6.39 %

Latent gain

-575.0 $

Invested capital

9000.0 $

Annualized return

3.12 %
Performance at glance (2Q Momentum)

Performance

-3.75 %

Latent gain

-262.5 $

Invested capital

7000.0 $

Annualized return

-1.02 %

Momentum equity curve on Analytica Limited

The following chart shows the equity curve of the two momentum strategies applied to Analytica Limited:

Analytica Limited momentum equity

Note: the dividends potentially given by Analytica Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Analytica Limited

The following chart shows the employed capital evolution of the two momentum strategies on Analytica Limited since the beginning:

Analytica Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Analytica Limited

Buy the dip entry openings on Analytica Limited

Analytica Limited

The performance achieved by the robo-advisor on Analytica Limited is 6.67%. That represents 50.0$ of latent gain with 750.0$ of employed capital. The following chart shows Analytica Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Analytica Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

6.67 %

Latent gain

50.0 $

Invested capital

750.0 $

Annualized return

3.12 %

Equity curve of the strategy applied to Analytica Limited

The following chart shows the result of the investment strategy applied to Analytica Limited:

Analytica Limited

Note: the dividends potentially given by Analytica Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Analytica Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Analytica Limited:

Analytica Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Analytica Limited

In this section, I will compare the three previous investment strategies applied to Analytica Limited.

Equity curve comparison on Analytica Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Analytica Limited investment strategy comparison

Employed capital comparison on Analytica Limited

Analytica Limited investment comparison

Performance comparison on Analytica Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -21.83% -545.84$ 2500.01$ -5.27%
Momentum 1 quarter -6.39% -575.0$ 9000.0$ -1.64%
Momentum 2 quarters -3.75% -262.5$ 7000.0$ -1.02%
Non-directional 6.67% 50.0$ 750.0$ 3.12%
Annualized return comparison

Automatic investment

-5.27 %

Momentum 1Q

-1.02 %

Momentum 2Q

-1.02 %

Non-directional

3.12 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Analytica Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Analytica Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Analytica Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Analytica Limited
Country Australia
City Brisbane
Address 320 Adelaide Street
Phone 61 7 3278 1950
Website www.analyticamedical.com
FullTime employees
Industry Medical Devices
Sector Healthcare
Exchange XASX
Ticker ALT.XASX
Market www2.asx.com.au

Analytica Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown